Litcius/Paper detail

Bactericidal efficacy of low dose gaseous ozone against clinically relevant multidrug-resistant bacteria

Bob Banerjee, Christine M. Thompson, Victor Nizet, Elisabet Bjånes

2024Frontiers in Microbiology10 citationsDOIOpen Access PDF

Abstract

Introduction: Healthcare-associated infections (HAIs) pose a significant challenge in acute care hospitals, particularly in intensive care units, due to persistent environmental contamination despite existing disinfection protocols and manual cleaning methods. Current disinfection methods are labor-intensive and often ineffective against multidrug-resistant (MDR) pathogens, highlighting the need for new, automated, hands-free approaches. Methods: This study evaluates the bactericidal efficacy of low concentrations of gaseous ozone (5 ppm) against clinically relevant and often MDR bacteria under various concentrations, contact times, temperatures, and environmental conditions. Results: upon ozone exposure. The bactericidal effect was dose-dependent, with no significant difference between single and repeated exposures. Environmental conditions such as temperature and humidity had minimal impact on low-dose ozone efficacy, with slightly improved bacterial killing at colder temperatures and higher humidity levels. Gaseous ozone also showed significant bactericidal activity against the broad range of Gram-positive and -negative MDR clinical isolates. Discussion: These findings highlight the potential of low-dose gaseous ozone as a versatile, effective, and hands-free disinfectant for healthcare and other settings. Further research is needed to establish long-term safety and efficacy guidelines for its use in occupied spaces and to explore potential synergy with other contemporary disinfection strategies.

Topics & Concepts

OzoneBacteriaMultiple drug resistanceMicrobiologyChemistryBiologyAntibioticsGeneticsOrganic chemistryInfection Control in HealthcareMedical and Biological Ozone ResearchMedical Device Sterilization and Disinfection
Bactericidal efficacy of low dose gaseous ozone against clinically relevant multidrug-resistant bacteria | Litcius